TKO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
TKO Group Holdings Inc is not a strong buy at this moment for a beginner investor with a long-term strategy. While the company has shown strong financial performance in Q4 2025 and has positive growth potential, the current pre-market price trend is slightly negative (-0.87%), and recent analyst ratings are mixed, with some downgrades citing valuation concerns. Additionally, options data indicates a bearish sentiment with high Put-Call ratios. Given the investor's impatience and unwillingness to wait for optimal entry points, it is advisable to hold off on buying until more favorable conditions arise.
The technical indicators suggest a mixed outlook. The MACD is positive and expanding, indicating bullish momentum. Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), and the RSI is neutral at 71.893. However, the pre-market price is down by -0.87%, and the stock has a 70% chance to decline by -1.24% in the next day and -0.95% in the next week. Key resistance levels are at R1: 222.521 and R2: 229.067, with support at S1: 201.327 and S2: 194.781.
Strong Q4 2025 earnings driven by media rights deals and share repurchase plans.
Hedge funds are significantly increasing their positions, with a 966.71% rise in buying activity last quarter.
Analysts from firms like UBS, Pivotal Research, and Bernstein have raised price targets, citing strong growth potential.
Seaport Research downgraded the stock to Neutral, citing valuation concerns and a lower-than-expected 2026 revenue outlook.
The company missed Q4 GAAP EPS expectations.
Options data reflects bearish sentiment, with high Put-Call ratios and increased put volume.
In Q4 2025, TKO reported a 12.1% YoY revenue increase and strong growth in net income (+77.23% YoY) and EPS (+67.86% YoY). Gross margin also improved significantly (+83.00% YoY). However, the company missed GAAP EPS expectations, and its 2026 revenue guidance is lighter than anticipated.
Analyst ratings are mixed. Positive ratings include UBS, Pivotal Research, and Bernstein, which raised price targets and highlighted strong growth potential. However, Seaport Research downgraded the stock to Neutral, citing valuation concerns and limited upside. Morgan Stanley maintained an Equal Weight rating, indicating balanced risk/reward.
